|
|
|
Volumn 104, Issue 9, 2001, Pages
|
|
Report From the 93rd Cardiovascular and Renal Drugs Advisory Committee Meeting, August 9-10, 2001.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BOSENTAN;
SULFONAMIDE;
CONFERENCE PAPER;
DRUG APPROVAL;
HUMAN;
PULMONARY HYPERTENSION;
ARTICLE;
FORCED EXPIRATORY VOLUME;
LUNG;
LUNG EMPHYSEMA;
PATHOLOGY;
PATHOPHYSIOLOGY;
RISK FACTOR;
SURVIVAL;
BLOOD PRESSURE;
DRUG EFFECT;
HEALTH SERVICE;
HYPERTENSION;
PRIMARY HEALTH CARE;
STATISTICS;
ANTIHYPERTENSIVE AGENTS;
DRUG APPROVAL;
HUMANS;
HYPERTENSION, PULMONARY;
SULFONAMIDES;
FORCED EXPIRATORY VOLUME;
LUNG;
PULMONARY EMPHYSEMA;
RISK FACTORS;
SURVIVAL ANALYSIS;
BLOOD PRESSURE;
HEALTH SERVICES;
HYPERTENSION;
PRIMARY HEALTH CARE;
|
|
EID: 0035964552
PISSN: 15244539
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
